Financial Advisor at Morgan Stanley Wealth Management
Location:
Portland, Maine
Industry:
Financial Services
Work:
Morgan Stanley Wealth Management - Portland, Maine Area since Dec 2012
Financial Advisor
Bellview Associates, LLC Aug 2011 - Nov 2012
Associate Analyst
The Chartroom Restaurant May 2009 - Oct 2010
Server/ Manager
Education:
University of Maine 2005 - 2010
Business, Finance
MDI
Skills:
Wealth Management Services Risk Management Financial Analysis Relationship Management Retirement Planning Portfolio Management Excel Mac OS X Microsoft Office Finance Access PowerPoint Microsoft Word Visio Outlook Teamwork SQL Visual Basic Financial Reporting Microsoft Excel
Certifications:
Series 7, Financial Industry Regulatory Authority (FINRA) Series 65, Financial Industry Regulatory Authority (FINRA) Series 63, Financial Industry Regulatory Authority (FINRA) Health, Life and Accident Insurance, Financial Industry Regulatory Authority (FINRA)
Dr. Shelton graduated from the Texas Tech University Health Science Center School of Medicine - Lubbock in 1995. He works in Irving, TX and specializes in Family Medicine. Dr. Shelton is affiliated with Baylor Scott & White Medical Center Irving.
License Records
Christopher B Shelton
License #:
23048 - Active
Category:
Tow Truck Operator (Incident Management)
Expiration Date:
Feb 27, 2018
Us Patents
Caenorhabditis Elegans Chemosensory Bioassay For Seven Transmembrane Receptor Ligands
George P. Livi - King of Prussia PA, US Christopher Shelton - King of Prussia PA, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
G01N033/00 A01K067/00 A01K067/033
US Classification:
800 3, 800 13
Abstract:
This invention relates to methods for producing a transgenic that expresses a human 7TMR pan-neuronally, such that said transgenic exhibits a known phenotype. These transgenic can be used in a variety of ways, including, but not limited to: (1) screening and identifying substances that bind to and activate particular human 7TMRs; (2) screening for substances that antagonize human 7TMR activation; (3) identifying human 7TMRs that may respond to particular substances; and (4) evaluating the specificity and efficacy of substances on human 7TMR activation.
Caenorhabditis Elegans Chemosensory Bioassay For Seven Transmembrane Receptor Ligands
George Livi - King of Prussia PA, US Christopher Shelton - King of Prussia PA, US
Assignee:
SmithKline Beecham Corporation
International Classification:
A01K067/033 A01K067/00
US Classification:
800/008000
Abstract:
This invention relates to methods for producing a transgenic that expresses a human 7TMR pan-neuronally, such that said transgenic exhibits a known phenotype. These transgenic can be used in a variety of ways, including, but not limited to: (1) screening and identifying substances that bind to and activate particular human 7TMRs; (2) screening for substances that antagonize human 7TMR activation; (3) identifying human 7TMRs that may respond to particular substances; and (4) evaluating the specificity and efficacy of substances on human 7TMR activation.
"Every one of us is here because of corporate greed," yelled Christopher Shelton, vice president of the regional branch of the Communication Workers of America. "It's time not to occupy Wall Street, but to take back Wall Street."